Clinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-Americans

Journal of Immigrant and Minority Health

Volumn 13, Issue 5, 2011, Pages 842-848

  Wong, Philip Y ^a   Xia, Victor ^b   Imagawa, David K ^a   Hoefs, John ^a   Hu, Ke Qin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asian Americans; Cirrhosis; Ethnicity; Hepatitis B; Hepatitis C; Hepatocellular carcinoma (HCC); Staging HCC

Indexed keywords

AGED; ARTICLE; ASIAN AMERICAN; COMPARATIVE STUDY; ETHNOLOGY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MEDICAL AUDIT; MIDDLE AGED; PATHOPHYSIOLOGY; UNITED STATES;

AGED; ASIAN AMERICANS; CALIFORNIA; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MEDICAL AUDIT; MIDDLE AGED;

EID: 81355139582     PISSN: 15571912     EISSN: 15571920     Source Type: Journal    
DOI: 10.1007/s10903-010-9395-8     Document Type: Article

References (43)

1. Bosch FX, Ribes J, Cleries R, et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2005;9:191-211. v. Review.
2. Kew MC. Epidemiology of hepatocellular carcinoma. Toxicology. 2002;181-182:35-8. (Pubitemid 36015669)
3. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271-85. (Pubitemid 29488770)
4. Howe HL, Wu X, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer. 2006;107:1711-42. (Pubitemid 44582941)
5. Wong R, Corley DA. Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. Am J Med. 2008;121:525-31. (Pubitemid 351694349)
6. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745-50. (Pubitemid 29114292)
7. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003;139:817.
8. Davila JA, Morgan RO, Shaib Y, et al. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology. 2004;127:1372-80. (Pubitemid 39457763)
9. Davila JA, Petersena NJ, Nelson HA, et al. Geographic variation within the United States in the incidence of hepatocellular carcinoma. J Clin Epidemiol. 2003;56:487-93. (Pubitemid 36694102)
10. Hwang SJ, Tong MJ, Lai PP, et al. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America. J Gastroenterol Hepatol. 1996;11:949-54. (Pubitemid 26338283)
11. Di Bisceglie AM, Lyra AC, Schwartz M, et al. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol. 2003;98:2060-3. (Pubitemid 37185806)
12. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer. 1996;77:2217-22. (Pubitemid 26162412)
13. Wong LL, Limm WM, Tsai N, Severino R. Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients. World J Gastroenterol. 2005;11:3491-7. (Pubitemid 40903499)
14. Davila JA, El-Serag HB. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clin Gastroenterol Hepatol. 2006;4:104-10. quiz 4-5. (Pubitemid 43129531)
15. Chin PL, Chu DZ, Clarke KG, Odom-Maryon T, Yen Y, Wagman LD. Ethnic differences in the behavior of hepatocellular carcinoma. Cancer. 1999;85:1931-6. (Pubitemid 29202766)
16. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-36. (Pubitemid 43112690)
17. Park JW, An M, Choi JI, et al. Accuracy of clinical criteria for the diagnosis of hepatocellular carcinoma without biopsy in a hepatitis B virus-endemic area. J Cancer Res Clin Oncol. 2007;133: 937-43. (Pubitemid 47561709)
18. Bonacini M, Hadi G, Govindarajan S, Lindsay KL. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1997;92:1302-4. (Pubitemid 27328588)
19. Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, editor. The liver and portal hypertension. Philadelphia, PA: Saunders; 1964. p. 50-64.
20. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864-71. (Pubitemid 30169932)
21. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual, 6th ed. New York: Springer-Verlag; 2002. p. 131.
22. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56:918-28. (Pubitemid 15228292)
23. The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology. 2000;31:840.
24. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol. 1994;17: 71-91.
25. Donato F, Tagger A, Gelatti U, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol. 2002;155:323-31. (Pubitemid 34132050)
26. Donato F, Tagger A, Gelatti U, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol. 2002;155:323-31. (Pubitemid 34132050)
27. Hu XS, Kyulo NL, Xia VW, et al. Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of US patients. J Clin Gastroenterol. 2009;43: 758-64.
28. Lai CJ, Nguyen TT, Hwang J, et al. Provider knowledge and practice regarding hepatitis B screening in Chinese-speaking patients. J Cancer Educ. 2007;22:37-41. (Pubitemid 47110499)
29. Hu KQ. Hepatitis B virus (HBV) infection in Asian and Pacific Islander Americans (APIAs): how can we do better for this special population? Am J Gastroenterol. 2008;103:1-10.
30. Hepatitis C. Global prevalence. Wkly Epidemiol Rec. 1997;72:341.
31. Tradati F, Colombo M, Mannucci PM, et al. A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. The study group of the association of Italian hemophilia centers. Blood. 1998;91:1173-7. (Pubitemid 28086869)
32. Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 1997;112:463-72. (Pubitemid 27078833)
33. Brechot C. Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma. Hepatology. 1997;25:772-4. (Pubitemid 27106469)
34. But DY, Lai CL, Yuen MF. Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol. 2008;14: 1652-6. (Pubitemid 351493370)
35. Welzel TM, Morgan TR, Bonkovsky HL. Variants in interferonalpha pathway genes and response to pegylated interferonalpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology. 2009;49:1847-58.
36. Lok AS, Seeff LB, Morgan TR, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009;136(1):138-48 (Epub 2008 Sep 18).
37. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005;25:181-200. (Pubitemid 40781071)
38. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907-17. (Pubitemid 37518510)
39. Masuzaki R, Omata M. Treatment of hepatocellular carcinoma. Indian J Gastroenterol. 2008;27:113-22.
40. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology. 2005;129:122-30. (Pubitemid 41002049)
41. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer. 2005;103:1201-9. (Pubitemid 40328091)
42. Hwang JP, Hassan MM. Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation. BMC Cancer. 2009;9:46.
43. Tong MJ, Chavalitdhamrong D, Lu DS, et al. Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA. J Clin Gastroenterol. 2009; 9 (Epub ahead of print).